Nothing Special   »   [go: up one dir, main page]

AYALA et al., 1986 - Google Patents

Evidence that a toxemia-related organism (Hydatoxi lualba) is an artifact

AYALA et al., 1986

Document ID
16770041006320348364
Author
AYALA A
DE LA FUENTE F
LOYA F
GONZÁLEZ E
KUNHARDT J
Publication year
Publication venue
Obstetrics & Gynecology

External Links

Snippet

Preeclampsia-eclampsia and trophoblastic disease have been associated with a wormlike organism, Hydatoxi lualba, recently discovered in smears from circulating blood, trophoblastic tumor tissue, and placental tissue of toxemic patients. To investigate these …
Continue reading at journals.lww.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
US20200171084A1 (en) Brain specific exosome based diagnostics and extracorporeal therapies
Ben-Bassat et al. Concanavalin A receptors on the surface membrane of lymphocytes from patient's with Hodgkin's disease and other malignant lymphomas.
AYALA et al. Evidence that a toxemia-related organism (Hydatoxi lualba) is an artifact
Herberman et al. Delayed Cutaneous Hypersensitivity Reactions to Extracts of Human Tumors 1.2
Gardner Observations on the cytology of gastric epithelium in tropical sprue
US5260186A (en) Provision of density specific blood cells for the structuredness of the cytoplasmic matrix (SCM) test
Zöller et al. Leukocyte migration studies in gastric cancer detection: an approach toward improved specificity and sensitivity
Link et al. Immunoglobulin abnormalities and measles antibody response in chronic myelopathy
Chisholm et al. Salivary proteins in Sjögren's syndrome: separation by isoelectric focusing in acrylamide gels
Morell et al. Leukocyte migration inhibition in farmer's lung
EP0172841B1 (en) Method for detecting malign proliferation
Brouland et al. Bone marrow involvement by disseminated toxoplasmosis in acquired immunodeficiency syndrome: the value of bone marrow trephine biopsy and immunohistochemistry for the diagnosis
Lundgren et al. Exfoliative cytology in laryngology: Comparison of cytologic and histologic diagnoses in 350 microlaryngoscopic examinations–A prospective study
JP2553606B2 (en) Method for separating and using density-specific blood cells
Acosta et al. Direct immunofluorescence on cytological smears in oral pemphigus
Evans et al. Cell‐mediated immune status of colon cancer patients. Evaluation by dermal antigen testing, measurement of lymphocyte stimulation and counts of peripheral blood rosette‐forming cells
AU638220B2 (en) Provision of density specific blood cells for the structuredness of the cytoplasmic matrix (scm) test
AMNIOTIC-FLUID et al. Response to hepatitis B virus vaccine in subjects with low levels of antibody to hepatitis B surface antigen
Iglehart et al. Function of the secretory immune system in bronchogenic carcinoma: Immunoglobulin A levels in respiratory secretions
Williams Preparation and use of malarial placenta antigen for immunodiffusion studies in a Nigerian population
Vassella et al. Basophils and eosinophils in human milk in relation to maternal allergy
Peller et al. Functions of polymorphonuclear (PMN) leukocytes of patients with lymphoproliferative diseases
Williamson et al. The rapid isolation from human blood of concentrated, white-cell-free preparations of Plasmodium falciparum
Bayne et al. Low cerebrospinal fluid sugar in meningeal carcinomatosis
US20240295547A1 (en) Method of simultaneously diagnosing active tuberculosis and latent tuberculosis infection using human whole blood sample-derived biomarker